SOLENO THERAPEUTICS INC - COM NEW (SLNO)

CUSIP: 834203200

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM NEW
Total 13F shares
28,482,131
Share change
-211,640
Total reported value
$26,310,750
Put/Call ratio
117%
Price per share
$0.92
Number of holders
34
Value change
-$433,787
Number of buys
13
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 834203200?
CUSIP 834203200 identifies SLNO - SOLENO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SOLENO THERAPEUTICS INC - COM NEW (SLNO) as of Q3 2021

As of 30 Sep 2021, SOLENO THERAPEUTICS INC - COM NEW (SLNO) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,482,131 shares. The largest 10 holders included Abingworth LLP, Nantahala Capital Management, LLC, ORACLE INVESTMENT MANAGEMENT INC, VANGUARD GROUP INC, TWO SIGMA ADVISERS, LP, Granite Point Capital Management, L.P., OPPENHEIMER & CO INC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, and STATE STREET CORP. This page lists 34 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.